Cargando…

Cross-presentation of Disialoganglioside GD3 to Natural Killer T Cells

GD3, a ganglioside expressed on human melanoma, can be recognized by the humoral immune system. In this paper, we demonstrate that immunizing mice with the human melanoma cell line SK-MEL-28 (GD3(+) GM2(−) CD1(−)) or with syngeneic APCs loaded with GD3 can induce a GD3-reactive natural killer T (NKT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Dianna Y., Segal, Neil H., Sidobre, Stephane, Kronenberg, Mitchell, Chapman, Paul B.
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2003
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2196074/ https://www.ncbi.nlm.nih.gov/pubmed/12847141 http://dx.doi.org/10.1084/jem.20030446

Ejemplares similares

Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular Subtypes
por: Erber, Ramona, et al.
Publicado: (2021)

Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins
Publicado: (1986)

Identification and Tumour-Binding Properties of a Peptide with High Affinity to the Disialoganglioside GD2
por: Müller, Jan, et al.
Publicado: (2016)

Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy
por: Nazha, Bassel, et al.
Publicado: (2020)

Targeting disialoganglioside GD2 with chimeric antigen receptor-redirected T cells in lung cancer
por: Reppel, Loïc, et al.
Publicado: (2022)

Disialoganglioside GD2-Targeted Near-Infrared Photoimmunotherapy (NIR-PIT) in Tumors of Neuroectodermal Origin
por: Inagaki, Fuyuki F., et al.
Publicado: (2022)

Structure Based Refinement of a Humanized Monoclonal Antibody That Targets Tumor Antigen Disialoganglioside GD2
por: Ahmed, Mahiuddin, et al.
Publicado: (2014)

Disialoganglioside GD2 distributes preferentially into substrate- associated microprocesses on human melanoma cells during their attachment to fibronectin
Publicado: (1986)

Bispecific antibody does not induce T-cell death mediated by chimeric antigen receptor against disialoganglioside GD2
por: Hoseini, Sayed Shahabuddin, et al.
Publicado: (2017)

Inhibition of Neuroblastoma Tumor Growth by Targeted Delivery of MicroRNA-34a Using Anti-Disialoganglioside GD(2) Coated Nanoparticles
por: Tivnan, Amanda, et al.
Publicado: (2012)

An Arg-Gly-Asp-directed receptor on the surface of human melanoma cells exists in an divalent cation-dependent functional complex with the disialoganglioside GD2
Publicado: (1987)

Successful engineering of a highly potent single-chain variable-fragment (scFv) bispecific antibody to target disialoganglioside (GD2) positive tumors
por: Cheng, Ming, et al.
Publicado: (2016)

Antigen specificity of invariant natural killer T-cells
por: Birkholz, Alysia M., et al.
Publicado: (2015)

Pharmacokinetics of the disialoganglioside, G(D2), a circulating tumor biomarker for neuroblastoma, in nonhuman primates
por: Balis, Frank M., et al.
Publicado: (2021)

Label-free in vitro assays predict the potency of anti-disialoganglioside chimeric antigen receptor T-cell products
por: Logun, Meghan, et al.
Publicado: (2023)

Activation of Natural Killer T Cells Potentiates or Prevents Experimental Autoimmune Encephalomyelitis
por: Jahng, Alex W., et al.
Publicado: (2001)

Cutaneous Immunization Rapidly Activates Liver Invariant Vα14 NKT Cells Stimulating B-1 B Cells to Initiate T Cell Recruitment for Elicitation of Contact Sensitivity
por: Campos, Regis A., et al.
Publicado: (2003)

Malignant phyllodes tumors display mesenchymal stem cell features and aldehyde dehydrogenase/disialoganglioside identify their tumor stem cells
por: Lin, Jin-Jin, et al.
Publicado: (2014)

Intravascular Immune Surveillance by CXCR6(+) NKT Cells Patrolling Liver Sinusoids
por: Geissmann, Frederic, et al.
Publicado: (2005)

CD1d-mediated Recognition of an α-Galactosylceramide by Natural Killer T Cells Is Highly Conserved through Mammalian Evolution
por: Brossay, Laurent, et al.
Publicado: (1998)

Cytokine-induced killer cells/natural killer cells combined with anti-GD2 monoclonal antibody increase cell death rate in neuroblastoma SK-N-SH cells
por: Zhang, Chi, et al.
Publicado: (2019)

Present and Future of Allogeneic Natural Killer Cell Therapy
por: Lim, Okjae, et al.
Publicado: (2015)

Tracking the Response of Natural Killer T Cells to a Glycolipid Antigen Using Cd1d Tetramers
por: Matsuda, Jennifer L., et al.
Publicado: (2000)

Initiation of immunotherapy with activated natural killer cells and anti-GD2 antibody dinutuximab prior to resection of primary neuroblastoma prolongs survival in mice
por: Zobel, Michael John, et al.
Publicado: (2020)

Natural Killer T Cell Ligand α-Galactosylceramide Enhances Protective Immunity Induced by Malaria Vaccines
por: Gonzalez-Aseguinolaza, Gloria, et al.
Publicado: (2002)

Constitutive Cytokine mRNAs Mark Natural Killer (NK) and NK T Cells Poised for Rapid Effector Function
por: Stetson, Daniel B., et al.
Publicado: (2003)

Extranasal natural killer/T-cell lymphoma initially presenting as myelofibrosis
por: Jang, Woori, et al.
Publicado: (2016)

Extranodal natural killer/T-cell lymphoma presenting as orbital cellulitis
por: Zuhaimy, Hanis, et al.
Publicado: (2017)

Natural killer cells and natural killer T cells in Lyme arthritis
por: Katchar, Kia, et al.
Publicado: (2013)

Natural Killer Cells in Asthma
por: Karimi, Khalil, et al.
Publicado: (2013)

Measurement of the neutron capture cross section for $^{155}$Gd and $^{157}$Gd for Nuclear Technology
por: Lo Meo, Sergio, et al.
Publicado: (2015)

The Vα14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode
por: Li, Yali, et al.
Publicado: (2010)

Roles of Natural Killer T Cells and Natural Killer Cells in Kidney Injury
por: Uchida, Takahiro, et al.
Publicado: (2019)

Antitumor Immunity Exerted by Natural Killer and Natural Killer T Cells in the Liver
por: Nakashima, Hiroyuki, et al.
Publicado: (2023)

Natural Killer Cell Enteropathy With Extraintestinal Involvement: Presenting as Symptomatic Anemia
por: Panigrahi, Manas Kumar, et al.
Publicado: (2021)

Calreticulin surface presentation: a signal for natural killer cells to attack
por: Castellanos, Jasmine P., et al.
Publicado: (2023)

The Src Family Tyrosine Kinase Fyn Regulates Natural Killer T Cell Development
por: Gadue, Paul, et al.
Publicado: (1999)

Natural Born Killers
Publicado: (1998)

Natural born killers.
por: Schmidt, C W
Publicado: (1998)

Natural killer T cells
por: Kanellopoulos, Jean
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_825hhu4rd8ci82c31p55vt36hi